BPC-157

• Peptide (Lyophilized) 5mg
• Liquid Arginate Form - 30ml / 1000mcg per ml / 30mg
• Dry-Fill Capsule Arginate Form - 500mcg / 60ct / 30mg
• Transdermal Gel - 50ml / 500mcg per 1ml pump / 25mg​​​​​​​​​​​​​​​​

• Angiogenesis promotion that supports new blood vessel growth, improving oxygen and nutrient delivery to injured tissue.
• Collagen synthesis support through increased fibroblast activity, strengthening connective tissue signaling and repair quality.
• Anti-inflammatory action that reduces localized and systemic inflammation signals, supporting recovery conditions.
• Cytoprotective properties that help protect cells from oxidative stress and inflammatory damage, improving cellular resilience and repair capacity.

• Accelerated healing signals in wound, ligament, tendon, and muscle recovery models.
• Gastrointestinal support signals relevant to ulcer models and intestinal repair paradigms.
• Nerve regeneration interest with potential support for nerve repair endpoints and broader inflammation reduction signals.

BPC-157 is frequently characterized as having a favorable tolerability profile, with relatively few adverse effects reported in research discussions. It is often described as well tolerated across animal research and human use contexts.